Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Update on the Risk of Breast Cancer with Hormone Replacement Therapy
Two recently published articles better describe the link between hormone replacement therapy (HRT) and risk of breast cancer. First, the increased risk of breast cancer occurs within 2 to 3 years of beginning hormone replacement therapy. Second, the risk of getting breast cancer decreases after you stop taking hormone replacement therapy. Hormone replacement therapy medicines include estrogens (Premarin), estradiol (Estrace, Climara, Vivelle and others), medroxyprogesterone (Provera, Cycrin), combination conjugated estrogens with medroxyprogesterone (Prempro, Premphase), and other progestins (progesterone, hydroxyprogesterone). For more information please visit: http://www3.interscience.wiley.com/journal/121645248/abstract and http://content.nejm.org/cgi/content/abstract/360/6/573
Learn More

Update on the Risk of Breast Cancer with Hormone Replacement Therapy
Two recently published articles better describe the link between hormone replacement therapy (HRT) and risk of breast cancer. First, the increased risk of breast cancer occurs within 2 to 3 years of beginning hormone replacement therapy. Second, the risk of getting breast cancer decreases after you stop taking hormone replacement therapy. Hormone replacement therapy medicines include estrogens (Premarin), estradiol (Estrace, Climara, Vivelle and others), medroxyprogesterone (Provera, Cycrin), combination conjugated estrogens with medroxyprogesterone (Prempro, Premphase), and other progestins (progesterone, hydroxyprogesterone). For more information please visit: http://www3.interscience.wiley.com/journal/121645248/abstract and http://content.nejm.org/cgi/content/abstract/360/6/573
Learn More

Receive Safety Alerts & Recalls by email or text message.

Register

Date Published Title Drug Source
2009-06-08 Update on the Risk of Breast Cancer with Hormone Replacement Therapy Medroxyprogesterone MediGuard CRT
2009-06-08 Update on the Risk of Breast Cancer with Hormone Replacement Therapy Estrogens Conjugated with Medroxyprogesterone MediGuard CRT
2009-06-08 Update on the Risk of Breast Cancer with Hormone Replacement Therapy Progesterone MediGuard CRT
2009-06-08 Update on the Risk of Breast Cancer with Hormone Replacement Therapy Hydroxyprogesterone MediGuard CRT
2009-06-04 Risk of Serious Liver Injury From Propylthiouracil Propylthiouracil FDA
2009-06-01 Select Antidepressants May Interact with Tamoxifen (Novaldex) Tamoxifen MediGuard CRT
2009-05-29 TNF Blockers Increase the Risk of Fungal Infections Golimumab Manufacturer
2009-05-28 Recall on Select Lots of Metoprolol Tartrate 100 mg Tablets Metoprolol FDA
2009-05-28 Recall on Single Lot of Zicam Multisymptom Cold & Flu Nighttime Formula Zicam FDA
2009-05-28 Recall on Single Lot of Zicam Multisymptom Cold & Flu Nighttime Formula Zicam Cold and Flu FDA
2009-05-27 Recall on Single lot of Klonopin Wafers (clonazepam orally disintegrating wafers) Clonazepam FDA
2009-05-13 National Recall on A S Medication Solutions Digoxin Digoxin FDA
2009-05-09 UPDATE: Nationwide Recall of Hydroxycut-Branded Products Hydroxycut FDA
2009-05-09 UPDATE: Nationwide Recall of Hydroxycut-Branded Products Hydroxycut Ephedra Free FDA
2009-05-09 New Warnings Added to the Labeling of Tarceva Erlotinib FDA
2009-05-07 Boxed Warning Added to Testosterone Gel Products (Androgel, Testim) Testosterone FDA
2009-05-06 FDA Approves Updated Labeling For Antiepileptic Medications Carbamazepine FDA
2009-05-06 FDA Approves Updated Labeling For Antiepileptic Medications Felbamate FDA
2009-05-06 FDA Approves Updated Labeling For Antiepileptic Medications Gabapentin FDA
2009-05-06 FDA Approves Updated Labeling For Antiepileptic Medications Lamotrigine FDA
Back to Consumer Med Safety